Literature DB >> 30808717

Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.

Chiko Shimbori1, Chandak Upagupta1, Pierre-Simon Bellaye1, Ehab A Ayaub1, Seidai Sato1, Toyoshi Yanagihara1, Quan Zhou1, Alexander Ognjanovic1, Kjetil Ask1, Jack Gauldie1, Paul Forsythe1,2, Martin R J Kolb1.   

Abstract

BACKGROUND: The role of mast cells accumulating in idiopathic pulmonary fibrosis (IPF) lungs is unknown.
OBJECTIVES: We investigated the effect of fibrotic extracellular matrix (ECM) on mast cells in experimental and human pulmonary fibrosis.
RESULTS: In IPF lungs, mast cell numbers were increased and correlated with disease severity (control vs 60%<FVC<90%, mean difference=-222.7, 95% CI -386.3 to -59.2, p=0.004; control vs FVC<60%, mean difference=-301.7, 95% CI of difference -474.1 to -129.34, p=0.0001; FVC>90% vs 60%<FVC<90%, mean difference=-189.6, 95% CI of difference -353.1 to -26.03, p=0.017; FVC>90% vs FVC<60%, mean difference=-268.6, 95% CI of difference -441.0 to -96.17, p=0.0007). Plasma tryptase levels were increased in IPF and negatively correlated with FVC (control vs FVC<60%, mean difference=-17.12, 95% CI of difference -30.02 to -4.22, p=0.006: correlation curves R=-0.045, p=0.025). In a transforming growth factor (TGF)-β1-induced pulmonary fibrosis model, chymase-positive and tryptase-positive mast cells accumulated in fibrotic lung. Lung tissue was decellularised and reseeded with bone marrow or peritoneum-derived mast cells; cells on fibrotic ECM released more TGF-β1 compared with normal ECM (active TGF-β1: bone marrow-derived mast cell (BMMC)-DL vs BMMC-TGF-β1 p=0.0005, peritoneal mast cell (PMC)-DL vs PMC-TGF-β1 p=0.0003, total TGF-β1: BMMC-DL vs BMMC-TGF-β1 p=0.013, PMC-DL vs PMC-TGF-β1 p=0.001). Mechanical stretch of lungs caused mast cell degranulation; mast cell stabilisers inhibited degranulation (histamine: cont vs doxantrazole p=0.004, β-hexosaminidase: cont vs doxantrazole, mean difference=1.007, 95% CI of difference 0.2700 to 1.744, p=0.007) and TGF-β1 activation (pSmad2/Smad2: cont vs dox p=0.006). Cromoglycate attenuated pulmonary fibrosis in rats (collagen: phosphate-buffered saline (PBS) vs cromoglycate p=0.036, fibrotic area: PBS vs cromoglycate p=0.031).
CONCLUSION: This study suggests that mast cells may contribute to the progression of pulmonary fibrosis. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  idiopathic pulmonary fibrosis; innate immunity; interstitial fibrosis

Mesh:

Substances:

Year:  2019        PMID: 30808717     DOI: 10.1136/thoraxjnl-2018-211516

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Mechanical Stretch: An Important and Understudied Feature of Acute and Chronic Lung Injury.

Authors:  Leigh M Cagino; Matthew K Hensley; Sean M Fortier; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

2.  Chelerythrine Ameliorates Pulmonary Fibrosis via Activating the Nrf2/ARE Signaling Pathway.

Authors:  Ling Peng; Li Wen; Qingfeng Shi; Feng Gao; Bin Huang; Changming Wang
Journal:  Cell Biochem Biophys       Date:  2021-02-12       Impact factor: 2.194

Review 3.  The Cellular and Molecular Effects of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia.

Authors:  Oluyinka O Olutoye Ii; Walker D Short; Jamie Gilley; J D Hammond Ii; Michael A Belfort; Timothy C Lee; Alice King; Jimmy Espinoza; Luc Joyeux; Krithika Lingappan; Jason P Gleghorn; Sundeep G Keswani
Journal:  Front Pediatr       Date:  2022-07-05       Impact factor: 3.569

4.  Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification.

Authors:  Tao Huang; Wei-Ying He
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

5.  Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.

Authors:  Catherine Overed-Sayer; Elena Miranda; Rebecca Dunmore; Elena Liarte Marin; Lorea Beloki; Doris Rassl; Helen Parfrey; Alan Carruthers; Amina Chahboub; Sofia Koch; Gülin Güler-Gane; Michael Kuziora; Arthur Lewis; Lynne Murray; Richard May; Deborah Clarke
Journal:  Thorax       Date:  2020-07-24       Impact factor: 9.139

6.  Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.

Authors:  Jianrong Yang; Chunxia Chen; Wan Chen; Luying Huang; Zhao Fu; Kun Ye; Liwen Lv; Zhihuang Nong; Xing Zhou; Wensheng Lu; Mei Zhong
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

Review 7.  The Role of Mast Cells in IgE-Independent Lung Diseases.

Authors:  Daniel Elieh Ali Komi; Esmaeil Mortaz; Saeede Amani; Angelica Tiotiu; Gert Folkerts; Ian M Adcock
Journal:  Clin Rev Allergy Immunol       Date:  2020-06       Impact factor: 8.667

8.  Mechanical stretch and LPS affect the proliferation, extracellular matrix remodeling and viscoelasticity of lung fibroblasts.

Authors:  Yongpeng Xie; Ying Qian; Yanli Wang; Kexi Liu; Xiaomin Li
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

Review 9.  Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis.

Authors:  Juntang Yang; Xin Pan; Lan Wang; Guoying Yu
Journal:  Mol Med       Date:  2020-10-14       Impact factor: 6.354

10.  Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.

Authors:  Roberta Fusco; Rosalba Siracusa; Ramona D'Amico; Marika Cordaro; Tiziana Genovese; Enrico Gugliandolo; Alessio Filippo Peritore; Rosalia Crupi; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.